Related Experiment Video
Updated: Jun 8, 2026

10:35
Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
Published on: September 20, 2015
Quantitative cerebral MR perfusion imaging: preliminary results in stroke
Maulin K Shah1, Wanyong Shin, Vishal S Parikh
1Department of Biomedical Engineering, Northwestern University, Evanston, Illinois 60611, USA.
Journal of Magnetic Resonance Imaging : JMRI
|October 1, 2010
Summary
Quantitative MRI perfusion (qCBF) effectively differentiates brain tissue in stroke patients. This method shows better discrimination of critically ischemic and presumed penumbra regions than traditional time-based metrics.
Area of Science:
- Neuroimaging
- Cerebrovascular Medicine
- Radiology
Background:
- Assessing cerebral blood flow (CBF) is crucial for managing ischemic stroke.
- Traditional metrics like time to peak (Tmax) and mean transit time (MTT) have limitations in stroke assessment.
- Quantitative MRI perfusion (qCBF) offers a potential alternative for evaluating cerebral perfusion.
Purpose of the Study:
- To evaluate quantitative cerebral blood flow (qCBF) against traditional time-based metrics (Tmax, MTT) in stroke patients.
- To determine the utility of qCBF in differentiating brain regions with varying degrees of ischemic injury.
Main Methods:
- Nine ischemic stroke patients underwent quantitative MRI perfusion using the Bookend method.
- Regions of interest (ROIs) were defined in critically ischemic (CI), presumed penumbra (PP), and presumed normal (PN) brain tissues.
- Mean values of qCBF, Tmax, and MTT were calculated for gray and white matter separately.
Main Results:
- qCBF measures significantly distinguished between CI and PP tissues, unlike Tmax and MTT.
- Receiver operating characteristic (ROC) analysis showed qCBF had high utility in discriminating between CI and PN regions (AUC=0.96).
- qCBF provided superior discrimination of CI and PP regions compared to Tmax and MTT (AUC=0.82 vs. 0.65 and 0.52).
Conclusions:
- Quantitative MRI perfusion is feasible in ischemic stroke patients.
- qCBF demonstrates enhanced discrimination of critically ischemic and penumbra tissues compared to time-based metrics.
- This qCBF strategy warrants further investigation in larger clinical trials.
